Optiwave Refractive Analysis (ORA)
The team at Gordon Schanzlin New Vision Institute Institute offers some of the most advanced technologies to help patients achieve the best possible results after treatment. The new Optiwave Refractive Analysis system (ORA) can maximize the potential for vision improvement after cataract surgery or laser vision correction treatment. This effective technology allows our eye surgeons to customize your vision more precisely than ever before.
For patients who undergo cataract surgery, ORA is a revolutionary new technology. Before ORA, measurements to evaluate your premium intraocular lens implant and ensure it was giving you proper vision correction after treatment could only be taken before the cataract was removed and the natural lens replaced. This left a margin of error – the cataract surgeon would need to wait several weeks in order to assess the effectiveness of the IOL and to know whether the best type of IOL was selected. ORA reduces the uncertainty and gives our eye surgeon the ability to verify proper selection of IOLs during the cataract surgery procedure. With ORA’s intraoperative aberrometer, our cataract surgeons can get a precise assessment of the IOL and how much vision improvement can be obtained from it without having to wait or make adjustments weeks after surgery.
ORA makes it possible to ensure you have the best possible vision improvement with your IOL. Although primarily utilized for cataract surgery patients, those who have astigmatism can also benefit from ORA technology. ORA can also be performed for patients who have previously had LASIK or PRK surgery and those who are undergoing placement of a multifocal lens implant, allowing our vision care physicians to further improve accuracy and optimize your results.
If you would like more information on our cataract surgery and vision care treatments, or if you would like to schedule a consultation with one of our experienced ophthalmologists, please contact Gordon Schanzlin New Vision Institute Institute today.
The doctors at Gordon Schanzlin New Vision Institute have either authored or reviewed and approved this content.